Trademark: 79277722
Status Date
Tuesday, January 11, 2022
Registration Number
6610076
Registration Date
Tuesday, January 11, 2022
Filing Date
Wednesday, September 25, 2019
Published for Opposition
Tuesday, October 26, 2021
5 Pharmaceutical preparations for human use, namely, pharmaceutical antibodies and their fragments and derivatives, cells and genes that produces antibodies, and fragments of antibodies and derivatives of antibodies, all for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities, for medical and pharmaceutical use
45 Granting of licenses to others for the use of industrial property rights and copyright
42 Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
Aug 1, 2022
Final Decision Transaction Processed By Ib
Jun 24, 2022
Generic Madrid Transaction Sent To Ib
Jun 23, 2022
Generic Madrid Transaction Created
Apr 11, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jan 11, 2022
Registered-Principal Register
Nov 4, 2021
Notification Processed By Ib
Oct 26, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 26, 2021
Published For Opposition
Oct 6, 2021
Notification Of Possible Opposition Sent To Ib
Oct 6, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 6, 2021
Notification Of Notice Of Publication E-Mailed
Sep 18, 2021
Exparte Appeal Terminated
Sep 17, 2021
Approved For Pub - Principal Register
Sep 17, 2021
Examiner's Amendment Entered
Sep 17, 2021
Notification Of Examiners Amendment E-Mailed
Sep 17, 2021
Examiners Amendment E-Mailed
Sep 17, 2021
Examiners Amendment -Written
Aug 3, 2021
Assigned To Examiner
Jul 24, 2021
Notification Of Possible Opposition - Processed By Ib
Jul 7, 2021
Notification Of Possible Opposition Sent To Ib
Jul 7, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Jun 23, 2021
Jurisdiction Restored To Examining Attorney
Apr 8, 2021
Notification Of Action Denying Req For Recon E-Mailed
Apr 8, 2021
Action Denying Req For Recon E-Mailed
Apr 8, 2021
Action Continuing Final - Completed
Mar 19, 2021
Teas Request For Reconsideration Received
Mar 19, 2021
Ex Parte Appeal-Instituted
Mar 19, 2021
Jurisdiction Restored To Examining Attorney
Mar 19, 2021
Exparte Appeal Received At Ttab
Sep 26, 2020
Notification Of Final Refusal Emailed
Sep 26, 2020
Final Refusal E-Mailed
Sep 26, 2020
Final Refusal Written
Sep 9, 2020
Teas/Email Correspondence Entered
Sep 8, 2020
Correspondence Received In Law Office
Sep 8, 2020
Teas Response To Office Action Received
Mar 31, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 31, 2020
Teas Change Of Correspondence Received
Mar 31, 2020
Teas Change Of Domestic Representatives Address
Mar 31, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 31, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 31, 2020
Teas Change Of Owner Address Received
Mar 21, 2020
Refusal Processed By Ib
Mar 5, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Mar 5, 2020
Refusal Processed By Mpu
Feb 12, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Feb 11, 2020
Non-Final Action Written
Feb 11, 2020
Application Filing Receipt Mailed
Feb 7, 2020
Assigned To Examiner
Feb 7, 2020
New Application Office Supplied Data Entered In Tram
Feb 6, 2020
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
